Minerval

N/A

Report date: 2024/07/01 15:40:32
NMEFirst In Class

Base Information

Drug NameMinerval
Drug Alias NameIdroxioleic acid2-OHOALP-561A1LP561A1LAM-561
ClassificationSmall molecules
Mechanisms of ActionSphingomyelin synthase activators
TargetsSphingomyelin synthase
Therapy Area/IndicationsSolid tumoursGlioblastomaGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItalyUnited Kingdom +[6
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursGlioblastomaGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank